It is now the second-largest developer of drugs, trailing only the United States. In the global drug development pipeline, China’s growth rate is phenomenal, leaping from 3 per cent in 2013 to…
Sovereign Wealth Funds Return to China and Hong Kong as Middle Eastern Investors Lead $14.2 Billion Surge
Middle Eastern sovereign investors are helping drive a rebound in capital flowing to China and Hong Kong, backing opportunities in technology, consumer brands and advanced industries. The $14.2 billion surge signals renewed interest, while persistent economic and geopolitical risks temper the outlook.



0 Comments